Literature DB >> 28839004

Ventilation and neurochemical changes during µ-opioid receptor activation or blockade of excitatory receptors in the hypoglossal motor nucleus of goats.

Thomas M Langer1, Suzanne E Neumueller1, Emma Crumley1, Nicholas J Burgraff1, Sawan Talwar1, Matthew R Hodges1,2, Lawrence Pan3, Hubert V Forster1,2,4.   

Abstract

Neuromodulator interdependence posits that changes in one or more neuromodulators are compensated by changes in other modulators to maintain stability in the respiratory control network. Herein, we studied compensatory neuromodulation in the hypoglossal motor nucleus (HMN) after chronic implantation of microtubules unilaterally ( n = 5) or bilaterally ( n = 5) into the HMN. After recovery, receptor agonists or antagonists in mock cerebrospinal fluid (mCSF) were dialyzed during the awake and non-rapid eye movement (NREM) sleep states. During day studies, dialysis of the µ-opioid inhibitory receptor agonist [d-Ala2, N-MePhe4, Gly-ol]enkephalin (DAMGO; 100 µM) decreased pulmonary ventilation (V̇i), breathing frequency ( f), and genioglossus (GG) muscle activity but did not alter neuromodulators measured in the effluent mCSF. However, neither unilateral dialysis of a broad spectrum muscarinic receptor antagonist (atropine; 50 mM) nor unilateral or bilateral dialysis of a mixture of excitatory receptor antagonists altered V̇i or GG activity, but all of these did increase HMN serotonin (5-HT) levels. Finally, during night studies, DAMGO and excitatory receptor antagonist decreased ventilatory variables during NREM sleep but not during wakefulness. These findings contrast with previous dialysis studies in the ventral respiratory column (VRC) where unilateral DAMGO or atropine dialysis had no effects on breathing and bilateral DAMGO or unilateral atropine increased V̇i and f and decreased GABA or increased 5-HT, respectively. Thus we conclude that the mechanisms of compensatory neuromodulation are less robust in the HMN than in the VRC under physiological conditions in adult goats, possibly because of site differences in the underlying mechanisms governing neuromodulator release and consequently neuronal activity, and/or responsiveness of receptors to compensatory neuromodulators. NEW & NOTEWORTHY Activation of inhibitory µ-opioid receptors in the hypoglossal motor nucleus decreased ventilation under physiological conditions and did not affect neurochemicals in effluent dialyzed mock cerebral spinal fluid. These findings contrast with studies in the ventral respiratory column where unilateral [d-Ala2, N-MePhe4, Gly-ol]enkephalin (DAMGO) had no effects on ventilation and bilateral DAMGO or unilateral atropine increased ventilation and decreased GABA or increased serotonin, respectively. Our data support the hypothesis that mechanisms that govern local compensatory neuromodulation within the brain stem are site specific under physiological conditions.

Entities:  

Keywords:  breathing; hypoglossal motor nucleus; neuromodulation; opioids

Mesh:

Substances:

Year:  2017        PMID: 28839004      PMCID: PMC5814683          DOI: 10.1152/japplphysiol.00592.2017

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  54 in total

1.  PreBotzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced respiratory depression.

Authors:  Gaspard Montandon; Wuxuan Qin; Hattie Liu; Jun Ren; John J Greer; Richard L Horner
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo.

Authors:  Xia Liu; Sandeep Sood; Hattie Liu; Richard L Horner
Journal:  J Physiol       Date:  2005-04-07       Impact factor: 5.182

3.  Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo.

Authors:  Mohammad Hajiha; Marq-André DuBord; Hattie Liu; Richard L Horner
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

4.  Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain.

Authors:  Nadir I Osman; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

5.  Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors.

Authors:  M C Bellingham; A J Berger
Journal:  J Neurophysiol       Date:  1996-12       Impact factor: 2.714

6.  State-dependent interactions between excitatory neuromodulators in the neuronal control of breathing.

Authors:  Atsushi Doi; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

Review 7.  The neuroanatomy of depression: A review.

Authors:  Peter Oakes; Marios Loukas; Rod J Oskouian; R Shane Tubbs
Journal:  Clin Anat       Date:  2016-10-28       Impact factor: 2.414

8.  Neuromodulation in the Treatment of Epilepsy.

Authors:  George Nune; Christopher DeGiorgio; Christianne Heck
Journal:  Curr Treat Options Neurol       Date:  2015-10       Impact factor: 3.598

Review 9.  Neuromodulation and the orchestration of the respiratory rhythm.

Authors:  Atsushi Doi; Jan-Marino Ramirez
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

Review 10.  The neuropharmacology of upper airway motor control in the awake and asleep states: implications for obstructive sleep apnoea.

Authors:  R L Horner
Journal:  Respir Res       Date:  2001-08-10
View more
  3 in total

Review 1.  Julius H. Comroe Distinguished Lecture: Interdependence of neuromodulators in the control of breathing.

Authors:  Hubert V Forster
Journal:  J Appl Physiol (1985)       Date:  2018-08-23

Review 2.  Opioids and obstructive sleep apnea.

Authors:  Carla Freire; Luiz U Sennes; Vsevolod Y Polotsky
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

3.  Dynamic Rhythmogenic Network States Drive Differential Opioid Responses in the In Vitro Respiratory Network.

Authors:  Nicholas J Burgraff; Nicholas E Bush; Jan M Ramirez; Nathan A Baertsch
Journal:  J Neurosci       Date:  2021-10-25       Impact factor: 6.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.